Helicobacter pylori infection and long term proton pump inhibitor therapy

Gut

Volumn 53, Issue 1, 2004, Pages 5-7

  McColl, K E L ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR;

ATROPHIC GASTRITIS; BACTERIAL INFECTION; CANCER RISK; DISEASE COURSE; DRUG POTENCY; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; LONG TERM CARE; NOTE; PRIORITY JOURNAL; PROTECTION; RISK FACTOR; STOMACH CANCER; STOMACH PH;

ANTI-ULCER AGENTS; GASTRITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PROTON PUMPS;

EID: 0347091966     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.53.1.5     Document Type: Note

References (30)

1. Kuipers EJ, Lundell L, Klinkenberg EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334:1018-22.
2. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 consensus report. Aliment Pharmacol Ther 2002;16:67-180.
3. Editor's update. Am J Gastroenterol 1997;92(suppl):55-56S.
4. Proton pump inhibitor relabelling for cancer risk not warranted. FDC Report, 11 November 1996.
5. Lundell L, Miettinen P, Myrvold HE, et al. Lack of effect of acid suppression therapy on gastric atrophy. Gastroenterology 1999;117:319-26.
6. Pounder RE, Williams MP. Omeprazole and accelerated onset of atrophic gastritis. Gastroenterology 2000;118:238-9.
7. McColl KEL, Murray LS, Gillen D. Omeprazole and accelerated onset of atrophic gastritis. Gastroenterology 2000;118:239.
8. Kuipers EJ, Klinkenberg-Knol EC, Meuwissen SGM. Omeprazole and accelerated onset of atrophic gastritis. Gastroenterology 2000;118:239-40.
9. Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, et al. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut 2004;53:12-20.
10. Uemura N, Okamoto S, Yamamoto S, et al. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan. Aliment Pharmacol Ther 2000;14:1345-52.
11. Geboes K, Dekker W, Mulder CJJ, et al. Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa. Aliment Pharmacol Ther 2001;18:1819-26.
12. Stolte M, Meining A, Schmitz JM, et al. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1998;12:247-53.
13. Singh P, Indaram A, Greenberg R, et al. Long term omeprazole therapy for reflux esophagitis: follow-up in serum gastrin levels, EC cell hyperplasia and neoplasia. World J Gastroenterol 2000;6:789-92.
14. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
15. Elzimaity HMT, Graham DY, Alossi MT, et al. Interobserver variation in the histopathological assessment of Helicobocter pylori gastritis. Hum Pathol 1996;27:35-41.
16. Raghunath A, Hungin APS, Wooff D, et al. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003;326:737-40.
17. + Helicobacter pylori in reflux oesophagitis. Gut 2001;49:341-6.
18. Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of CagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998;115:50-7.
19. Labenz J, Blum AL, Bayerdorffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-7.
20. Moayyedi P, Bardhan C, Young L, et al. Helicobacter pylori eradication does not exacerbate reflux symptoms in gostroesophageal reflux disease. Gastroenterology 2001;121:1120-6.
21. Schwizer W, Thumshirn M, Dent J, et al. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet 2001;357:1738-42.
22. McColl KEL, Gillen D. Helicobacter pylori and reflux disease. Lancet 2001;358:1730.
23. Koike T, Ohara S, Sekine H, et al. Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis. Aliment Pharmacol Ther 2001;15:813-20.
24. El-Omar EM, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997;113:15-24.
25. Verdu EF, Armstrong D, Fraser R, et al. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 1995;36:539-43.
26. Vendu EF, Armstrong D, Idstrom J-P, et al. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 1995;37:743-8.
27. Holtmann G, Cain C, Malfertheiner P. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology 1999;117:11-16.
28. Hatlebakk JG, Hyggen A, Madsen PH, et al. Heartburn treatment in primary care: randomized, double-blind study for 8 weeks. BMJ 1999;319:550-4.
29. Gillen D, Wirz AA, Ardill JE, et al. Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterology 1999;116:239-47.
30. Gillen D, Wirz A, McColl KEL. Eradication of H pylori unleashes post PPI acid hypersecretion. Gastroenterology 2002;122:A-101.